# Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation

> **NCT02710188** · PHASE1 · COMPLETED · sponsor: **Nxera Pharma UK Limited** · enrollment: 14 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** HTL0009936 modified release
- **DRUG:** HTL0009936 immediate release

## Key facts

- **NCT ID:** NCT02710188
- **Lead sponsor:** Nxera Pharma UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02710188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02710188, "Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02710188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*